Total Payments
$1,037
2024 Payments
$222.89
Companies
19
Transactions
64
Medicare Patients
1,566
Medicare Billing
$179,810
Payment Breakdown by Category
Food & Beverage$997.95 (96.3%)
Other$38.65 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $997.95 | 62 | 96.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38.65 | 2 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $250.14 | 29 | $0 (2022) |
| IRONSHORE PHARMACEUTICALS INC. | $157.79 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $103.68 | 5 | $0 (2024) |
| Shire North American Group Inc | $103.64 | 5 | $0 (2017) |
| PTC Therapeutics, Inc. | $93.99 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $43.02 | 2 | $0 (2019) |
| Acorda Therapeutics, Inc | $38.65 | 2 | $0 (2017) |
| Tris Pharma Inc | $33.95 | 2 | $0 (2021) |
| PFIZER INC. | $23.94 | 1 | $0 (2023) |
| ARGENX US, INC. | $23.62 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.89 | 10 | IRONSHORE PHARMACEUTICALS INC. ($117.26) |
| 2023 | $64.81 | 3 | PFIZER INC. ($23.94) |
| 2022 | $26.76 | 2 | Supernus Pharmaceuticals, Inc. ($26.76) |
| 2021 | $215.18 | 26 | Supernus Pharmaceuticals, Inc. ($186.60) |
| 2020 | $47.21 | 3 | Supernus Pharmaceuticals, Inc. ($24.53) |
| 2019 | $88.06 | 5 | Novartis Pharmaceuticals Corporation ($41.10) |
| 2018 | $125.11 | 3 | PTC Therapeutics, Inc. ($93.99) |
| 2017 | $246.58 | 12 | Shire North American Group Inc ($103.64) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Neurology | ||||||
| 11/25/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.75 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/01/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.46 | General |
| 09/24/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.59 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/29/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Neurology | ||||||
| 07/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Neurology | ||||||
| 02/29/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/20/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.22 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/08/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PAIN | ||||||
| 10/11/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Neurology | ||||||
| 07/13/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: PSYCHOLOGY | ||||||
| 01/24/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $11.90 | General |
| Category: PSYCHOLOGY | ||||||
| 12/20/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: PSYCHOLOGY | ||||||
| 12/14/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $10.17 | General |
| Category: PSYCHOLOGY | ||||||
| 12/08/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $4.45 | General |
| Category: PSYCHOLOGY | ||||||
| 12/01/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $6.01 | General |
| Category: PSYCHOLOGY | ||||||
| 11/21/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $7.29 | General |
| Category: PSYCHOLOGY | ||||||
| 11/20/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $5.50 | General |
| Category: PSYCHOLOGY | ||||||
| 11/10/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $10.40 | General |
| Category: PSYCHOLOGY | ||||||
| 10/29/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $4.88 | General |
| Category: PSYCHOLOGY | ||||||
| 10/27/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $6.86 | General |
| Category: PSYCHOLOGY | ||||||
| 10/04/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.66 | General |
| Category: PSYCHOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 433 | 506 | $133,470 | $51,321 |
| 2022 | 7 | 433 | 492 | $119,405 | $44,977 |
| 2021 | 9 | 377 | 415 | $93,090 | $39,664 |
| 2020 | 7 | 323 | 369 | $105,105 | $43,848 |
Total Patients
1,566
Total Services
1,782
Medicare Billing
$179,810
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 130 | $35,750 | $11,720 | 32.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 30 | 30 | $22,800 | $9,707 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $24,150 | $7,919 | 32.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 71 | 71 | $17,395 | $7,586 | 43.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 48 | $17,280 | $6,701 | 38.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 60 | 85 | $6,375 | $3,433 | 53.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 50 | $6,500 | $3,244 | 49.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 23 | 23 | $3,220 | $1,011 | 31.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 105 | 107 | $25,970 | $11,147 | 42.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 32 | 32 | $23,760 | $10,320 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 56 | $15,080 | $5,467 | 36.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 76 | $9,880 | $4,433 | 44.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $11,405 | $4,381 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 54 | $7,710 | $3,010 | 39.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 60 | 87 | $6,825 | $2,702 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $4,795 | $1,704 | 35.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 18 | 19 | $11,435 | $907.85 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 11 | $2,545 | $904.43 | 35.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 76 | 78 | $18,720 | $8,962 | 47.9% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 18 | 18 | $14,850 | $7,157 | 48.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 57 | $7,980 | $4,081 | 51.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 48 | 58 | $7,565 | $3,551 | 46.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 20 | $6,800 | $3,412 | 50.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 71 | 86 | $7,310 | $2,775 | 38.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $5,415 | $2,772 | 51.2% |
About Dr. Malcolm Mcharg, MD
Dr. Malcolm Mcharg, MD is a Neurology healthcare provider based in Blue Bell, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689614042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malcolm Mcharg, MD has received a total of $1,037 in payments from pharmaceutical and medical device companies, with $222.89 received in 2024. These payments were reported across 64 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($997.95).
As a Medicare-enrolled provider, Mcharg has provided services to 1,566 Medicare beneficiaries, totaling 1,782 services with total Medicare billing of $179,810. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology with Special Qualifications in Child Neurology
- Location Blue Bell, PA
- Active Since 06/07/2006
- Last Updated 07/21/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1689614042
Products in Payments
- QELBREE (Drug) $213.36
- JORNAY PM (Drug) $157.79
- MYDAYIS (Drug) $85.08
- KESIMPTA (Drug) $62.58
- MAYZENT (Drug) $41.10
- AMPYRA (Drug) $38.65
- TROKENDI XR (Drug) $25.26
- COPAXONE (Drug) $24.21
- NURTEC ODT (Drug) $23.94
- VYVGART HYTRULO (Drug) $23.62
- Dyanavel XR (Drug) $22.68
- ONFI (Drug) $21.25
- Evekeo (Drug) $21.20
- NAMZARIC (Drug) $18.99
- AJOVY (Drug) $18.81
- TYSABRI (Biological) $18.64
- VYVANSE (Drug) $18.56
- Aimovig (Biological) $18.07
- MIGRANAL (Drug) $15.90
- UBRELVY (Drug) $13.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Blue Bell
Vidhu Gupta, Ma, MA
Neurology — Payments: $5,743
Neurology $5,743
George Dooneief, Md, MD
Neurology — Payments: $1,863
Neurology $1,863
Igor Porotov, M.d, M.D
Neurology — Payments: $1,403
Neurology $1,403
Laurance Smith, Md, MD
Neurology — Payments: $929.73
Neurology $929.73
Lawrence Kerson, Md, MD
Neurology — Payments: $250.00
Neurology $250.00